INSIGHTS ON PHARMACEUTICAL PACKAGING

• New Guidelines For Container Closure Integrity Testing

  Increased regulatory scrutiny and exciting new analytical technologies have altered the landscape of container closure integrity testing. In order to provide guidance to this new environment the US Pharmacopoeia revised Chapter <1207> Sterile Product Package Integrity.  View this webinar recording to learn about the new guidelines and how they will impact your approach to sterile product package integrity.

• Meeting Patient Needs Through Expedited Delivery Of Phase I Materials

  To quickly deliver their product to patients in need, Reneo Pharma found a partner to provide both product development and clinical packaging services.

• 4 Reasons Blow/Fill/Seal Technology Should Be Considered For Aseptic Filling

  Drug manufacturers seeking alternative methods for a safe and reliable approach to drug delivery should consider blow-fill-seal technology, as it offers several benefits over traditional glass packaging.

• Meet Aggressive Timelines By Simplifying Your Drug Delivery Supply Chain

  To meet an aggressive timeline with a lack of resources, Kaleido Biosciences had to consider an alternative yet efficient route for drug substance, drug product, and clinical trial packaging needs.

• Track-And-Trace In The Drug Supply Chain

  Though the timelines may vary, across the globe more and more countries are requiring product identifiers and serialization of prescription drugs — right down to individual salable units. 

• Specialized Pharmaceutical Packaging Solutions

  Specialized packaging solutions to address the increasing focus of developing and bringing more advanced medicines and niche orphan drugs to market.

• Considerations For Late-Stage Customization

  Learn how streamlining operations and using a process called Late Stage Customization you can significantly reduce costs to ensure a more efficient, flexible supply chain.

• Ensuring Strength And Flexibility Of Single-Use Bags In All Applications

  The costs are high when leakage occurs during steps that are critical to patient safety. Read how the robustness of Sartorius films makes them safe and easy to use for all process steps and applications.

• The Benefits Of Late-Stage Customization For Orphan Drug Manufacturing

  Almac explains how, through the use of the Hapa BlisterJet printer, they are able to maximize the stock flexibility of their clients’ valuable orphan drug products, meaning they can distribute product more efficiently between different European countries.